A selective HPLC method for determination of lercanidipine in tablets.
An HPLC reversed phase method using both UV (356 nm) and electrochemical (1000 mV) detection was developed in order to determine lercanidipine in commercial tablets. Repeatability and reproducibility were adequate. For quantification we have used the calibration plot method for lercanidipine concentration ranging between 1 x 10(-5) and 1 x 10(-4) M. Also, the proposed method is sufficiently selective to distinguish the parent drug and the degradation products after hydrolysis, photolysis or chemical oxidation. Furthermore, the typical excipients included in the drug formulation (talc, lactose, cornstarch, microcrystalline cellulose, carboxymethylcellulose and magnesium stearate) do not interfere with the selectivity of the method. Finally, the proposed chromatographic method was successfully applied to the quantitative determination of lercanidipine in commercial tablets.
Alvarez-Lueje
A
A
Bioelectrochemistry Laboratory, Chemical and Pharmaceutical Sciences Faculty, University of Chile, P.O. Box 233, 1, Santiago, Chile. aalvarezl@entelchile.net
Pujol
S
S
Squella
J A
JA
Núñez-Vergara
L J
LJ
D002121:Calcium Channel Blockers / Q000032:analysis*; D002138:Calibration; D002851:Chromatography, High Pressure Liquid; D004095:Dihydropyridines / Q000032:analysis*; D004563:Electrochemistry; D006358:Hot Temperature; D006868:Hydrolysis; D007202:Indicators and Reagents; D010084:Oxidation-Reduction; D010782:Photolysis; D012996:Solutions; D013056:Spectrophotometry, Ultraviolet; D013607:Tablets
D002121:Calcium Channel Blockers; D004095:Dihydropyridines; D007202:Indicators and Reagents; D012996:Solutions; D013607:Tablets; C060343:lercanidipine